Rezydent Bułkasp. j.

Renting and operating of own or leased real estate

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-04-07
Registered address
ul. Jana Barona 37/1, 43-100 Tychy, Poland
Electronic delivery address
AE:PL-74623-54362-JWRUC-25

Financials

Filing timeliness

No financial statement for 2022 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2021, 20 days late).

  • 2022not filed
  • 202104/08/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2021.

Results vs industry

Revenue
This companyUSD 118.59kMedianUSD 193.80kAverageUSD 1.37m
Net profit
This companyUSD 38.23kMedianUSD 7.25kAverageUSD 125.83k
Operating costs
This companyUSD 78.68kMedianUSD 132.33kAverageUSD 940.78k
Assets
This companyUSD 1.04mMedianUSD 765.00kAverageUSD 6.95m

Ownership

Owner
Helena Maria Bułkaage 62
Mirosław Roman Bułkaage 65

Manner of representation

Each partner has the right to represent the partnership independently, subject to the proviso that in matters: 1. concerning the assumption of obligations or the disposal of a right with a value exceeding PLN 20,000.00 (twenty thousand złoty); 2. encumbering the partnership's assets with limited rights in rem; 3. granting loans and guarantees; 4. signing bills of exchange; 5. collective redundancies of employees, a partner is authorised to represent the partnership only jointly with another partner and, if a commercial proxy has been appointed, jointly with a commercial proxy.

Helena Maria Bułka and Mirosław Roman Bułka – all partners share the same surname, so the structure looks family-owned.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2011-08-12.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282

Competitors

FAQ

Last updated: 2026-04-20